CHDR1417: test-retest reliability of, and effect of retigabine and riluzole on, peripheral motor nerve excitebility measurements in ALS

Diagnosis ALS
Study phase Completed
Participating centres UMC Utrecht

A phase I, randomized, double blind, double-dummy placebo controlled, 3-way cross-over study to determine the test-retest reliability of, and the effect of oral retigabine and riluzole on, peripheral motor nerve excitability measurements in patients with ALS.

Read more on the results (in Dutch)

 

Read more on clinicaltrialsregister.eu